Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi's Multaq will no longer be reimbursed in France
Reuters
Thursday, November 17, 2011 - 9:05am
tags:
Sanofi, France, Euripe, Multaq
3 Cancer Immunotherapy Biotechs With Catalysts For 2012
Seeking Alpha
Thursday, November 17, 2011 - 9:03am
tags:
Alnylam, Dendreon, GSK, Medivation, ImmunoCellular, Novartis, cancer, NewLink Genetics
FDA grants priority review to Chelsea's hypotension drug
Reuters
Thursday, November 17, 2011 - 9:01am
tags:
FDA, Chelsea Therapeutics, hypotension, Northera
Meda Agrees to Buy Three Drugs From J&J for $110.5 Million
Bloomberg
Thursday, November 17, 2011 - 9:00am
tags:
Meda, JNJ, OTC
Pfizer's rare disease drug gets EU nod
Reuters
Thursday, November 17, 2011 - 8:58am
tags:
Pfizer, Europe, Vyndaqel, transthyretin familial amyloid polyneuropathy
Keeping An Eye On Both BioSante And Antares Pharma
Seeking Alpha
Wednesday, November 16, 2011 - 5:24pm
tags:
BioSante, Antares, LibiGel
Procter & Gamble's High Hopes for Joint Venture
TheStreet.com
Wednesday, November 16, 2011 - 5:23pm
tags:
P&G, Teva Pharmaceuticals, PGT Healthcare
J&J starts removing toxins from baby products
Yahoo/AP
Wednesday, November 16, 2011 - 5:21pm
tags:
JNJ
Quick review of Eliquis could lift Bristol, Pfizer
Reuters
Wednesday, November 16, 2011 - 5:20pm
tags:
Pfizer, Eliquis, Bristol-Myers Squibb, bloodthinner
Over 20% in US "took at least one mental health drug in 2010"
Pharma Times, UK
Wednesday, November 16, 2011 - 11:35am
tags:
anxiety, ADHD
Bayer chief aims for 37% pharma growth in China
Fierce Pharma
Wednesday, November 16, 2011 - 11:31am
tags:
Bayer, China
Human Genome says albiglutide payments could reach $183M
Yahoo
Wednesday, November 16, 2011 - 10:54am
tags:
Human Genome Sciences, albiglutide, GSK, diabetes
Pending clinicals, Oncolytics could be target
The Deal
Wednesday, November 16, 2011 - 10:51am
tags:
Oncolytics, M&A, Reolysin, cancer
Geron's Shift Opens The Door Wide For InVivo
Seeking Alpha
Wednesday, November 16, 2011 - 10:41am
tags:
InVivo, Geron, stem cells
Gilead and J&J expand HIV cocktail partnership
Yahoo/AP
Wednesday, November 16, 2011 - 9:51am
tags:
Gilead, JNJ, HIV, Tibotec, Prezista, Emtriva, cobicistat, GS 7340
Amarin Stabilizes Ahead Of FDA Decision
Seeking Alpha
Wednesday, November 16, 2011 - 9:49am
tags:
Amarin, FDA, AMR101
Biotech startup Allena Pharma raises $15M
Bizjournals.com
Wednesday, November 16, 2011 - 9:47am
tags:
Allena Pharma, venture capital, Series A
High Plavix doses overcome genetic barrier-study
Reuters
Wednesday, November 16, 2011 - 9:46am
tags:
Plavix, bloodthinners, Sanofi, Bristol-Myers Squibb
Why Bristol-Myers Squibb's Earnings Are Outstanding
Motley Fool
Wednesday, November 16, 2011 - 9:45am
tags:
Bristol-Myers Squibb, earnings
CEO Interview: Novartis' Joe Jimenez
Smart Money
Tuesday, November 15, 2011 - 5:19pm
tags:
Pharma CEOs, Joe Jimenez, Novartis, eye health

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.